Schrödinger’s stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion
Schrödinger Inc.’s stock soared 14% Tuesday to put in on track for its biggest one-day gain in a year, after the company said ...
FierceBiotech2d
Novartis pays Schrödinger $150M, bets billions on the back end to form drug discovery pact
Novartis is paying $150 million for a closer look at Schrödinger’s catalog of programs. The Big Pharma will work with Schrödinger to advance some of the computing-enabled R&D shop’s discovery programs ...
Novartis shines a light on skin disease using testimonials and digital touchpoints
Hidradenitis suppurativa (HS) is a relatively common skin disease, affecting as many as one percent of people worldwide. But ...
Marketing Interactive2d
MediaSense acquires R3 North America and Asia operations
Independent global media advisor MediaSense, has acquired R3, the creative and media advisory for an undisclosed amount, to ...
The Business Journals2d
St. Louis cancer-drug startup names new medical chief
Thomas also held leadership posts with Novartis, Bristol-Myers Squibb, Beigene, GSK and Amgen. Thomas received a bachelor's ...
BioPharma Dive3d
FDA approves new CAR-T competitor to Gilead’s Tecartus
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...